Independent science and medical journalism
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 400 | Founded | 4 years ago | Last Issue | 2 days ago |
| Active | |||||
Read this Newsletter
blog.maryannedemasi.comLatest Issues
CDC nominee faces a loyalty test
Before Dr Erica Schwartz could convince senators she was ready to lead the CDC, she first had to convince them she would not stray from the accepted boundaries on vaccines.
This week, Dr Erica Schwartz appeared before the Senate HELP Commi...
Lowering blood pressure in older adults comes with risks
Deprescribing may be the better option
Recently, I wrote about how blood pressure guidelines have steadily shifted lower. Treatment thresholds fell, risk calculators expanded, and far more people now start medication years before they deve...
Elsevier sued over continued sale of discredited Study 329
A new lawsuit argues that the publisher should be required to warn customers about key facts surrounding Study 329 before selling access to the paper. I spoke with the attorney behind the case.
Study 329, published in the Journal of the Am...
Kulldorff exposes HPV vaccine's illusion of safety
One of the world's leading biostatisticians says the science used to reassure regulators about Gardasil was fundamentally flawed.
One of the world’s leading biostatisticians has concluded that key analyses used to reassure regulators and t...
The Lancet's latest mRNA review reads more like marketing than science
The authors call mRNA vaccines safe, effective & transformative. But the review is largely performative. It raises controversial questions only to defuse them with reassuring conclusions.
The Lancet’s latest review of mRNA vaccines, by Bla...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for MD REPORTS.
| Subscribers | Engagement | 85 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #39 | |
| #25 |
Authors
The writers behind this newsletter.
Maryanne Demasi PhD is an investigative journalist who writes for online media and top tiered medical journals. For over a decade, she was a TV presenter for the Australian Broadcasting Corporation (ABC).
Social
Frequently Asked Questions
How can I access the email archive for MD REPORTS?
You can find recent issues that have been published by MD REPORTS on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does MD REPORTS have?
To see how many people subscribe to MD REPORTS, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in MD REPORTS?
Newsletter advertising can be extremely effective when it's done right. Before you pitch MD REPORTS as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like MD REPORTS?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact MD REPORTS using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to MD REPORTS?
Scroll up to where it says Related Newsletters to see other publications like MD REPORTS. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact MD REPORTS?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.